These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19055998)

  • 1. Continuation or withdrawal of beta-blocker therapy in patients admitted for heart failure.
    Bouzas-Mosquera A; Peteiro J; Alvarez-García N
    J Am Coll Cardiol; 2008 Dec; 52(24):2044; author reply 2044-5. PubMed ID: 19055998
    [No Abstract]   [Full Text] [Related]  

  • 2. [A must in symptomatic heart failure. Added beta blocker improves prognosis].
    MMW Fortschr Med; 2001 Feb; 143(5):50-1. PubMed ID: 11234521
    [No Abstract]   [Full Text] [Related]  

  • 3. Ask the doctor. I have diabetes, coronary artery disease, and heart failure. My doctor wants me to take a beta blocker, but I have heard that these drugs might be dangerous for people like me. Should I follow her advice?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393348
    [No Abstract]   [Full Text] [Related]  

  • 4. [Beta-blocker therapy in heart failure: rational basis, indications, dosages and cautions].
    Branzi A; Rapezzi C; Galiè N
    G Ital Cardiol; 1988 Dec; 18(12):1072-9. PubMed ID: 2908108
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta blocker in heart failure. A little is better than nothing].
    MMW Fortschr Med; 2003 Oct; 145(41):47. PubMed ID: 14655485
    [No Abstract]   [Full Text] [Related]  

  • 7. beta-Blocker therapy for congestive heart failure: clinical considerations.
    Kamath SA; Yancy CW
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of beta blocker and digoxin alone and in combination for management of patients with atrial fibrillation and heart failure.
    Fauchier L; Grimard C; Pierre B; Nonin E; Gorin L; Rauzy B; Cosnay P; Babuty D; Charbonnier B
    Am J Cardiol; 2009 Jan; 103(2):248-54. PubMed ID: 19121446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker therapy for patients with ventricular heart failure and reduced systolic function.
    Giles TD
    Postgrad Med; 2003 Dec; 114(6 Suppl Role):18-29. PubMed ID: 19667666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will beta-blockers save money?
    Heidenreich PA
    J Card Fail; 2005 Dec; 11(9):657-8. PubMed ID: 16360959
    [No Abstract]   [Full Text] [Related]  

  • 12. Validity, prognostic value and optimal cutoff of respiratory muscle strength in patients with chronic heart failure changes with beta-blocker treatment.
    Frankenstein L; Nelles M; Meyer FJ; Sigg C; Schellberg D; Remppis BA; Katus HA; Zugck C
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):424-9. PubMed ID: 19474739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice.
    Go AS; Yang J; Gurwitz JH; Hsu J; Lane K; Platt R
    Arch Intern Med; 2008 Dec; 168(22):2415-21. PubMed ID: 19064823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. About "Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy".
    Carvalho VO
    Cardiovasc Ther; 2009; 27(3):221. PubMed ID: 19689621
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
    Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
    Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting heart rate does not reflect the degree of beta-blockade in subjects with heart failure on chronic beta-blocker therapy.
    Mignatti A; Sims DB; Colombo PC; Garcia LI; Bijou R; Deng MC; Jorde UP
    Cardiovasc Ther; 2009; 27(1):42-8. PubMed ID: 19207479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure.
    McMurray JJ; Pitt B; Latini R; Maggioni AP; Solomon SD; Keefe DL; Ford J; Verma A; Lewsey J;
    Circ Heart Fail; 2008 May; 1(1):17-24. PubMed ID: 19808266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nebivolol (Bystolic): overview of a third generation beta-blocker.
    Strain J; Brown L
    S D Med; 2008 Jun; 61(6):219-20. PubMed ID: 18990852
    [No Abstract]   [Full Text] [Related]  

  • 20. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction.
    Hamdani N; Paulus WJ; van Heerebeek L; Borbély A; Boontje NM; Zuidwijk MJ; Bronzwaer JG; Simonides WS; Niessen HW; Stienen GJ; van der Velden J
    Eur Heart J; 2009 Aug; 30(15):1863-72. PubMed ID: 19487234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.